Last reviewed · How we verify

NCT03332914

A Crossover Designed Study to Evaluate Effects of Microcurrent Therapy on Knee Osteoarthritis

Completed NA Last updated 13 August 2019
What this trial tests

NA trial testing Microcurrent therapy in Osteoarthritis, Knee in 13 participants. Completed in 27 December 2017.

Timeline
2 November 2017
Primary endpoint
27 November 2017
27 December 2017

Quick facts

Lead sponsorLudwig-Maximilians - University of Munich
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment13
Start date2 November 2017
Primary completion27 November 2017
Estimated completion27 December 2017
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Ludwig-Maximilians - University of Munich

Who can join

18 and older, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This crossover designed study evaluates the effects of microcurrent therapy on knee osteoarthritis. Ín a previous study patients were randomized into four different groups. Group 1 and 2 both received microcurrent therapy, but with different freqency and intensity parameters. Group 3 received treatment with the microcurrent treatment apparatus without current (sham). group 4 was a control group. In the following, present study the controll group as well as the sham group will receive the microcurrent therapy (verum).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Microcurrent therapy

Trials testing the same drug.

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Ludwig-Maximilians - University of Munich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03332914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing